undamentalytics Newsletter
Sign in

Health Catalyst, Inc. income statement

In fiscal 2025, Health Catalyst, Inc. reported revenue of $311m, up 1.5% on the year before, operating income of −$161m (a -51.7% margin) and net income of −$178m, or −$2.55 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue73113155189242276296307311292
Research and development28394654637673585043
Selling and marketing26444755758867545245
General and administrative15233259866277575053
Operating income−46−60−55−96−144−140−127−70−161−247
Provision for credit losses—001012121
Income before tax——————−118−69−177—
Income tax0−00−1−7−40011
Net income−47−62−60−115−153−137−118−70−178−265
Diluted EPS−$1.52−$2.97−$6.43−$2.91−$3.23−$2.63−$2.09−$1.15−$2.55−$3.68
Diluted shares (average)39m38m37m40m47m54m56m60m70m72m
EBITDA−40−53−46−77−106−92−85−28−110−198

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HCAT vs HSTMDH vs HCATAMWL vs HCAT

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Health Catalyst, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Health Catalyst, Inc.